62
Participants
Start Date
September 30, 2015
Primary Completion Date
July 31, 2022
Study Completion Date
May 31, 2023
Octreotide
Two injections of 20 mg will be given monthly.
Gelre Hospital, Apeldoorn
Radboud University Medical Center (Radboudumc), Nijmegen
Jeroen Bosch Hospital, 's-Hertogenbosch
Catharina Hospital, Eindhoven
Elisabeth-TweeSteden Hospital, Tilburg
Reinier de Graaf Gasthuis, Delft
St. Antonius Hospital, Nieuwegein
Rijnstate Hospital, Arnhem
University Medical Center Groningen (UMCG), Groningen
Tjongerschans Hospital, Heerenveen
Maasstad Hospital, Rotterdam
Bernhoven Hospital, Uden
Jeroen Bosch Ziekenhuis
OTHER
Elisabeth-TweeSteden Ziekenhuis
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Bernhoven Hospital
OTHER
Tjongerschans hospital
UNKNOWN
Gelre Hospitals
OTHER
Maasstad Hospital
OTHER
Reinier de Graaf Groep
OTHER
University Medical Center Groningen
OTHER
Rijnstate Hospital
OTHER
St. Antonius Hospital
OTHER
Radboud University Medical Center
OTHER